HESTER BIOSCIENCES LTD Intrinsic Value
HESTERBIO · Healthcare · Current price ₹2,447.8
Is HESTER BIOSCIENCES LTD undervalued?
DocStoX estimates the fair value of HESTER BIOSCIENCES LTD at ₹1,007 per share, versus the current market price of ₹2,448. That puts the stock about -58.9% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹487), Relative P/E (₹2,167), Graham floor (₹789). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹487 (bear) to ₹1,007 (base) to ₹2,167 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹2,448 versus an intrinsic value of ₹1,007, HESTER BIOSCIENCES LTD currently offers -58.9% of negative margin (i.e. a premium).
More on HESTER BIOSCIENCES LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.